IMMUNIC, INC. Files Q1 2025 10-Q Report
Ticker: IMUX · Form: 10-Q · Filed: May 15, 2025 · CIK: 1280776
| Field | Detail |
|---|---|
| Company | Immunic, INC. (IMUX) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
IMMUNIC Q1 2025 10-Q filed. Financials and ops update.
AI Summary
IMMUNIC, INC. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as VITAL THERAPIES INC, is based in New York and operates in the pharmaceutical preparations sector. Key financial data and operational details for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational updates for IMMUNIC, INC. during the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly filing providing financial and operational updates, not indicating immediate high risk.
Key Numbers
- 2025 Q1 — Reporting Period (First quarter of 2025)
- 2024-12-31 — Previous Year End (End of fiscal year 2024)
- 2024-01-01 to 2024-03-31 — Prior Year Q1 Period (First quarter of 2024 for comparison)
Key Players & Entities
- IMMUNIC, INC. (company) — Filer of the 10-Q report
- VITAL THERAPIES INC (company) — Former name of IMMUNIC, INC.
- 20250331 (date) — End of the reporting period
- 20250515 (date) — Filing date of the report
- 1200 AVENUE OF THE AMERICAS (location) — Business and mailing address
FAQ
What is the primary business of IMMUNIC, INC.?
IMMUNIC, INC. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code [2834].
When was the company formerly known as VITAL THERAPIES INC?
The company changed its name from VITAL THERAPIES INC on February 19, 2004.
What is the fiscal year end for IMMUNIC, INC.?
The fiscal year end for IMMUNIC, INC. is December 31.
Where is IMMUNIC, INC. located?
IMMUNIC, INC. is located at 1200 Avenue of the Americas, Suite 200, New York, NY 10036.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding IMMUNIC, INC. (IMUX).